When it comes to treating common diseases, physicians have a near-dizzying array of treatment options at their disposal.
Take coronary artery disease. There’s bypass surgery. There’s medication. There’s devices such as stents. Or drug-coated stents. And if a pill or device is involved, then there’s the question of which brand or model.
In short, it can be like standing in the cereal aisle at a supermarket. With so many choices, how’s a doctor to decide what’s best?
A new federal research priority is aiming to empower doctors, as well as patients and health-insurance companies, with better information for making these kinds of decisions. The shift could have major implications for Minnesota’s health-care and medical-device companies. (Continue reading…)